The Relationship Between Neuropathic Complaints and Central Sensitization in Fibromyalgia
NCT ID: NCT05701696
Last Updated: 2023-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
111 participants
OBSERVATIONAL
2023-01-16
2023-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Relationship Between Central Sensitization Symptoms and Cognitive Dysfunction in Fibromyalgia
NCT06948903
Pain Phenotypes in Patients with Fibromyalgia Syndrome
NCT05941780
Pain Severity in Fibromyalgia Syndrome
NCT05481086
The Effect of Central Sensitization on Treatment Response in Patients With Fibromyalgia
NCT05020600
Fibromyalgia Syndrome on Patients With Chronic Migraine
NCT05381012
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with fibromyalgia
Patients diagnosed with FM according to ACR 2016 criteria
Central sensitization inventory
Standardized questionnaire to determine the level of central sensitization. Patients with a score of 40 and above are considered to have central sensitization.
Widespread pain index
Total the number of painful body areas
Symptom severity scale
The sum of the fatigue, waking unrefreshed and cognitive symptoms and the extent of somatic symptoms
Fibromyalgia impact questionnaire
A tool to assess health status in fibromyalgia
Hospital Anxiety and Depression Scale
An instrument for detecting depression and anxiety
Self-Leeds Assessment of Neuropathic Symptoms and Signs
An instrument used to identify pain of neuropathic origin
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Central sensitization inventory
Standardized questionnaire to determine the level of central sensitization. Patients with a score of 40 and above are considered to have central sensitization.
Widespread pain index
Total the number of painful body areas
Symptom severity scale
The sum of the fatigue, waking unrefreshed and cognitive symptoms and the extent of somatic symptoms
Fibromyalgia impact questionnaire
A tool to assess health status in fibromyalgia
Hospital Anxiety and Depression Scale
An instrument for detecting depression and anxiety
Self-Leeds Assessment of Neuropathic Symptoms and Signs
An instrument used to identify pain of neuropathic origin
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Between the ages of 18-65
* Agree to participate in the study
Exclusion Criteria
* Refusing to participate in the study
* Polyneuropathy, entrapment neuropathy, and radiculopathy are other diagnosed sources of neuropathic pain.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Marmara University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Feyza Nur Yücel, MD
Role: PRINCIPAL_INVESTIGATOR
Saglik Bilimleri Universitesi
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Health Sciences
Istanbul, Uskudar, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Woolf CJ, Thompson SW, King AE. Prolonged primary afferent induced alterations in dorsal horn neurones, an intracellular analysis in vivo and in vitro. J Physiol (Paris). 1988-1989;83(3):255-66.
Bhargava J, Goldin J. Fibromyalgia. 2025 Jan 31. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK540974/
Pomares FB, Funck T, Feier NA, Roy S, Daigle-Martel A, Ceko M, Narayanan S, Araujo D, Thiel A, Stikov N, Fitzcharles MA, Schweinhardt P. Histological Underpinnings of Grey Matter Changes in Fibromyalgia Investigated Using Multimodal Brain Imaging. J Neurosci. 2017 Feb 1;37(5):1090-1101. doi: 10.1523/JNEUROSCI.2619-16.2016. Epub 2016 Dec 16.
Martinez-Lavin M. Fibromyalgia in women: somatisation or stress-evoked, sex-dimorphic neuropathic pain? Clin Exp Rheumatol. 2021 Mar-Apr;39(2):422-425. doi: 10.55563/clinexprheumatol/0c7d6v. Epub 2020 Sep 16.
Ubeda-D'Ocasar E, Valera-Calero JA, Gallego-Sendarrubias GM, Fernandez-de-Las-Penas C, Arias-Buria JL, Morales-Cabezas M, Arendt-Nielsen L, Cigaran-Mendez M. Association of Neuropathic Pain Symptoms with Sensitization Related Symptomatology in Women with Fibromyalgia. Biomedicines. 2022 Mar 6;10(3):612. doi: 10.3390/biomedicines10030612.
Bennett M. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain. 2001 May;92(1-2):147-57. doi: 10.1016/s0304-3959(00)00482-6.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70. doi: 10.1111/j.1600-0447.1983.tb09716.x.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22/640
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.